CARLOMAGNO, Chiara
CARLOMAGNO, Chiara
DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA
The first breast cancer screening program in southern Italy: preliminary results from three municipalities of the Naples Province.
1995 DE PLACIDO, Sabino; F., Nuzzo; F., Perrone; Carlomagno, Chiara; A., Noviello; P., Delrio; E., di Palma; M. T., Pini; P. L., Cerato; C., Bianco
Endocrine factors in the outcome of systemic adjuvant therapy of early breast cancer.
1993 A. R., Bianco; DE PLACIDO, Sabino; F., Perrone; Carlomagno, Chiara; DE LAURENTIIS, Michelino; L., Del Mastro; R., Lauria; Marinelli, Alfredo; C., Gallo
c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases.
1996 Carlomagno, Chiara; F., Perrone; C., Gallo; DE LAURENTIIS, Michelino; R., Lauria; A., Morabito; Pettinato, Guido; L., Panico; A., D'Antonio; A. R., Bianco; DE PLACIDO, Sabino
Selecting high-risk early breast cancer patients: what to add to the number of metastatic nodes?
1996 F., Perrone; Carlomagno, Chiara; R., Lauria; DE LAURENTIIS, Michelino; A., Morabito; L., Panico; Pettinato, Guido; G., Petrella; C., Gallo; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino
The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancer.
1999 DE PLACIDO, Sabino; Lauria, Rossella; Carlomagno, Chiara; F., Perrone; DE LAURENTIIS, Michelino; C., Gallo; A., Martignetti; T., Bellelli; Limite, Gennaro; Petrella, Giuseppe; Bianco, ANGELO RAFFAELE
Prognostic significance of multifocality in primary breast cancer.
1994 Morabito, A.; Perrone, F.; Lauria, R.; Carlomagno, Chiara; Marinelli, Alfredo; DE LAURENTIIS, Michelino; Martignetti, A.; Pettinato, Guido; Panico, L.; Petrella, G.; Gallo, C.; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino
Combination chemotherapy with CMF (Cyclophosphamide, Metotrexate, 5-Fluorouracil versus CNF (Mitoxantrone, Fluorouracil, Cyclophosphamide) in advanced breast cancer. A multicenter randomized study.
1993 Lorusso, V.; De Lena, M.; Lopez, M.; DE PLACIDO, Sabino; Vici, P.; Piano, A.; Palomba, G.; Carlomagno, Chiara; D’Aprile, M.; Fosser, V.; Brandi, M.; Bianco, A. R.
Prognostic significance of necrosis, elestosis, fibrosis and inflammatory cell reaction in operable breast cancer.
1995 Carlomagno, Chiara; Perrone, F.; Lauria, R.; DE LAURENTIIS, Michelino; Gallo, C.; Morabito, A.; Pettinato, Guido; Panico, L.; Bellelli, T.; Apicella, A.; Putrella, G.; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino
The prognostic value of lymphatic and blood vessel invasion in operable breast cancer.
1995 Lauria, R.; Perrone, F.; Carlomagno, Chiara; DE LAURENTIIS, Michelino; Morabito, A.; Gallo, C.; Varriale, E.; Pettinato, Guido; Panico, L.; Petrella, G.; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino
Adjuvant chemoendocrine therapy for early breast cancer: is it worthwhile?
1995 Perrone, F.; DE PLACIDO, Sabino; Gallo, C.; Carlomagno, Chiara; Lauria, R.; Bianco, ANGELO RAFFAELE
DNA-flow cytometry (ploidy and S-phase fraction) as prognostic factor in a retrospectine series of 515 primary breast cancer.
1995 Pepe, S.; Ruggiero, A.; DE LAURENTIIS, Michelino; Normanno, N.; Fiorentino, B.; Perrone, F.; Carlomagno, Chiara; DE PLACIDO, Sabino; Panico, L.; Pettinato, Guido; Borriello, G.; Bianco, ANGELO RAFFAELE
Cancro del colon-retto
2007 Carlomagno, Chiara; DE PLACIDO, Sabino; Bianco, Ar
Activity and safety of pegylated liposomal doxorubicin, 5-fluorouracil and folinic acid in inoperable hepatocellular carcinoma: a phase II study.
2007 Di Lorenzo, G; Rea, A; Carlomagno, Chiara; Pepe, S; Palmieri, Giovannella; Labianca, R; Chirianni, A; De Stefano, A; Esposito, V; DE PLACIDO, Sabino; Montesarchio, V.
Chemotherapy with mitomycin C and vinblastine in pretreated metastatic breast cancer.
1993 F., Perrone; DE PLACIDO, Sabino; Carlomagno, Chiara; F., Nuzzo; A., Ruggiero; DE LAURENTIIS, Michelino; C., Gridelli; Pagliarulo, Clorindo; Bianco, ANGELO RAFFAELE
Mitomycin C and mitoxantrone in anthracycline-pretreated advanced breast cancer patients. A phase II study.
1994 F., Perrone; DE PLACIDO, Sabino; Carlomagno, Chiara; A., Gravina; DE LAURENTIIS, Michelino; L., Del Mastro; C., Gridelli; Pagliarulo, Clorindo; Bianco, ANGELO RAFFAELE
CMF vs alternating CMF/EV in the adjuvant treatment of operable breast cancer. A single centre randomised clinical trial (Naples GUN-3 study).
1995 DE PLACIDO, Sabino; F., Perrone; Carlomagno, Chiara; A., Morabito; Pagliarulo, Clorindo; Lauria, Rossella; Marinelli, Alfredo; DE LAURENTIIS, Michelino; E., Varriale; Petrella, Giuseppe
First-line systemic therapy for metastatic breast cancer and management of pleural effusion.
1995 F., Perrone; Carlomagno, Chiara; DE PLACIDO, Sabino; Lauria, Rossella; A., Morabito; Bianco, ANGELO RAFFAELE
A Metanalysis on the Interaction between HER2 Expression and Response to Endocrine Treatment in Advanced Breast Cancer
2005 DE LAURENTIIS, Michelino; Arpino, Grazia; Massarelli, E; Ruggiero, A; Carlomagno, Chiara; Ciardiello, F; Tortora, G; D’Agostino, D; Caputo, F; Cancello, G; Montagna, E; Malorni, L; Zinno, L; Lauria, R; Bianco, Ar; DE PLACIDO, Sabino
Vinorelbine + mitomycin C as second-line treatment of metastatic breast cancer: a two-stage phase 2 study.
2000 DE PLACIDO, Sabino; Lauria, Rossella; F., Perrone; Vernaglia, LOMBARDI ALESSANDRA; Carlomagno, Chiara; E., Varriale; Costanzo, Raffaele; L., Leo; DE LAURENTIIS, Michelino; Bianco, ANGELO RAFFAELE
Second-line chemotherapy with a hybrid-alternating regimen of bolus 5FU modulated by methotrexate and infusional 5FU modulated by folinic acid in patients with metastatic colorectal cancer pretreated with 5FU. A phase 2 study.
2002 Carlomagno, Chiara; Lauria, Rossella; DE LAURENTIIS, Michelino; Arpino, Grazia; Massarelli, Erminia; Ferrara, Claudia; Milano, Andrea; Vernaglia, LOMBARDI ALESSANDRA; Costanzo, Raffaele; G., Catalano; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino
Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
---|---|---|---|---|
The first breast cancer screening program in southern Italy: preliminary results from three municipalities of the Naples Province. | 1.1 Articolo in rivista | 1995 | DE PLACIDO, Sabino; F., Nuzzo; F., Perrone; Carlomagno, Chiara; A., Noviello; P., Delrio; E., di Palma; M. T., Pini; P. L., Cerato; C., Bianco | |
Endocrine factors in the outcome of systemic adjuvant therapy of early breast cancer. | 1.1 Articolo in rivista | 1993 | A. R., Bianco; DE PLACIDO, Sabino; F., Perrone; Carlomagno, Chiara; DE LAURENTIIS, Michelino; L., Del Mastro; R., Lauria; Marinelli, Alfredo; C., Gallo | |
c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases. | 1.1 Articolo in rivista | 1996 | Carlomagno, Chiara; F., Perrone; C., Gallo; DE LAURENTIIS, Michelino; R., Lauria; A., Morabito; Pettinato, Guido; L., Panico; A., D'Antonio; A. R., Bianco; DE PLACIDO, Sabino | |
Selecting high-risk early breast cancer patients: what to add to the number of metastatic nodes? | 1.1 Articolo in rivista | 1996 | F., Perrone; Carlomagno, Chiara; R., Lauria; DE LAURENTIIS, Michelino; A., Morabito; L., Panico; Pettinato, Guido; G., Petrella; C., Gallo; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino | |
The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancer. | 1.1 Articolo in rivista | 1999 | DE PLACIDO, Sabino; Lauria, Rossella; Carlomagno, Chiara; F., Perrone; DE LAURENTIIS, Michelino; C., Gallo; A., Martignetti; T., Bellelli; Limite, Gennaro; Petrella, Giuseppe; Bianco, ANGELO RAFFAELE | |
Prognostic significance of multifocality in primary breast cancer. | 1.1 Articolo in rivista | 1994 | Morabito, A.; Perrone, F.; Lauria, R.; Carlomagno, Chiara; Marinelli, Alfredo; DE LAURENTIIS, Michelino; Martignetti, A.; Pettinato, Guido; Panico, L.; Petrella, G.; Gallo, C.; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino | |
Combination chemotherapy with CMF (Cyclophosphamide, Metotrexate, 5-Fluorouracil versus CNF (Mitoxantrone, Fluorouracil, Cyclophosphamide) in advanced breast cancer. A multicenter randomized study. | 1.1 Articolo in rivista | 1993 | Lorusso, V.; De Lena, M.; Lopez, M.; DE PLACIDO, Sabino; Vici, P.; Piano, A.; Palomba, G.; Carlomagno, Chiara; D’Aprile, M.; Fosser, V.; Brandi, M.; Bianco, A. R. | |
Prognostic significance of necrosis, elestosis, fibrosis and inflammatory cell reaction in operable breast cancer. | 1.1 Articolo in rivista | 1995 | Carlomagno, Chiara; Perrone, F.; Lauria, R.; DE LAURENTIIS, Michelino; Gallo, C.; Morabito, A.; Pettinato, Guido; Panico, L.; Bellelli, T.; Apicella, A.; Putrella, G.; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino | |
The prognostic value of lymphatic and blood vessel invasion in operable breast cancer. | 1.1 Articolo in rivista | 1995 | Lauria, R.; Perrone, F.; Carlomagno, Chiara; DE LAURENTIIS, Michelino; Morabito, A.; Gallo, C.; Varriale, E.; Pettinato, Guido; Panico, L.; Petrella, G.; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino | |
Adjuvant chemoendocrine therapy for early breast cancer: is it worthwhile? | 1.1 Articolo in rivista | 1995 | Perrone, F.; DE PLACIDO, Sabino; Gallo, C.; Carlomagno, Chiara; Lauria, R.; Bianco, ANGELO RAFFAELE | |
DNA-flow cytometry (ploidy and S-phase fraction) as prognostic factor in a retrospectine series of 515 primary breast cancer. | 1.1 Articolo in rivista | 1995 | Pepe, S.; Ruggiero, A.; DE LAURENTIIS, Michelino; Normanno, N.; Fiorentino, B.; Perrone, F.; Carlomagno, Chiara; DE PLACIDO, Sabino; Panico, L.; Pettinato, Guido; Borriello, G.; Bianco, ANGELO RAFFAELE | |
Cancro del colon-retto | 2.1 Contributo in volume (Capitolo o Saggio) | 2007 | Carlomagno, Chiara; DE PLACIDO, Sabino; Bianco, Ar | |
Activity and safety of pegylated liposomal doxorubicin, 5-fluorouracil and folinic acid in inoperable hepatocellular carcinoma: a phase II study. | 1.1 Articolo in rivista | 2007 | Di Lorenzo, G; Rea, A; Carlomagno, Chiara; Pepe, S; Palmieri, Giovannella; Labianca, R; Chirianni, A; De Stefano, A; Esposito, V; DE PLACIDO, Sabino; Montesarchio, V. | |
Chemotherapy with mitomycin C and vinblastine in pretreated metastatic breast cancer. | 1.1 Articolo in rivista | 1993 | F., Perrone; DE PLACIDO, Sabino; Carlomagno, Chiara; F., Nuzzo; A., Ruggiero; DE LAURENTIIS, Michelino; C., Gridelli; Pagliarulo, Clorindo; Bianco, ANGELO RAFFAELE | |
Mitomycin C and mitoxantrone in anthracycline-pretreated advanced breast cancer patients. A phase II study. | 1.1 Articolo in rivista | 1994 | F., Perrone; DE PLACIDO, Sabino; Carlomagno, Chiara; A., Gravina; DE LAURENTIIS, Michelino; L., Del Mastro; C., Gridelli; Pagliarulo, Clorindo; Bianco, ANGELO RAFFAELE | |
CMF vs alternating CMF/EV in the adjuvant treatment of operable breast cancer. A single centre randomised clinical trial (Naples GUN-3 study). | 1.1 Articolo in rivista | 1995 | DE PLACIDO, Sabino; F., Perrone; Carlomagno, Chiara; A., Morabito; Pagliarulo, Clorindo; Lauria, Rossella; Marinelli, Alfredo; DE LAURENTIIS, Michelino; E., Varriale; Petrella, Giuseppe | |
First-line systemic therapy for metastatic breast cancer and management of pleural effusion. | 1.1 Articolo in rivista | 1995 | F., Perrone; Carlomagno, Chiara; DE PLACIDO, Sabino; Lauria, Rossella; A., Morabito; Bianco, ANGELO RAFFAELE | |
A Metanalysis on the Interaction between HER2 Expression and Response to Endocrine Treatment in Advanced Breast Cancer | 1.1 Articolo in rivista | 2005 | DE LAURENTIIS, Michelino; Arpino, Grazia; Massarelli, E; Ruggiero, A; Carlomagno, Chiara; Ciardiello, F; Tortora, G; D’Agostino, D; Caputo, F; Cancello, G; Montagna, E; Malorni, L; Zinno, L; Lauria, R; Bianco, Ar; DE PLACIDO, Sabino | |
Vinorelbine + mitomycin C as second-line treatment of metastatic breast cancer: a two-stage phase 2 study. | 1.1 Articolo in rivista | 2000 | DE PLACIDO, Sabino; Lauria, Rossella; F., Perrone; Vernaglia, LOMBARDI ALESSANDRA; Carlomagno, Chiara; E., Varriale; Costanzo, Raffaele; L., Leo; DE LAURENTIIS, Michelino; Bianco, ANGELO RAFFAELE | |
Second-line chemotherapy with a hybrid-alternating regimen of bolus 5FU modulated by methotrexate and infusional 5FU modulated by folinic acid in patients with metastatic colorectal cancer pretreated with 5FU. A phase 2 study. | 1.1 Articolo in rivista | 2002 | Carlomagno, Chiara; Lauria, Rossella; DE LAURENTIIS, Michelino; Arpino, Grazia; Massarelli, Erminia; Ferrara, Claudia; Milano, Andrea; Vernaglia, LOMBARDI ALESSANDRA; Costanzo, Raffaele; G., Catalano; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino |